FAST Grants Terms and Conditions
FAST’s grants and fellowship programs aim to encourage therapeutic translational research agendas focusing on potential treatments, research or biomarker and outcome measure development that will greatly enhance the progress of these platforms toward human benefit for Angelman syndrome (AS).
FAST New Investigator Award—This award will be granted to a promising new scientist that is looking to start a significant research program focusing on translational research in Angelman syndrome, or on technologies specifically relevant to advancing Angelman Syndrome treatment modalities. This award is geared toward financially supporting the start-up needs for this investigator for 2 years, with the potential of a one-year extension, with the one-year extension at an additional $125,000. This award will be a two-year grant, in the amount of $250,000/year. Potential allowable costs are the same as that for a FAST-TRAC award. While this is a two-year grant, each year of funding will be based on review of the prior year’s progress report. A progress report to include a financial report is required at the 11th month from award activation date. A final report, including financials, will be required at the end of the two-year award period.
Prohibition of Discrimination
No person shall be excluded from participation in or denied the benefits of any program or activity receiving financial assistance from FAST because of race, ethnic origin, religion, age, sex or sexual orientation.
Amendment of Policies
FAST reserves the right to modify its policies governing research awards at any time. The recipient agrees to abide by any changes or to terminate the grant at the time when such changes become effective. Failure to abide by the policies governing awards shall be considered sufficient grounds for cancellation of an award or refusal to consider any pending application by the grantee.